Evidence map›Paper›PMID 39829241›Full record

ReviewChemical research in toxicology2025

Analytical Quality Evaluation of the Tox21 Compound Library.

Ann M Richard, Dingyin Tao, Christopher A LeClair, William Leister, Kirill V Tretyakov, Edward White, Ken C Lewis, Andrea Sefler, Paul Shinn, Bradley J Collins and 10 more

Abstract readReview
In one paragraph

Review in Chemical research in toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. CombinedJournal of chemical information and modeling · 2025
    Article
  8. Gaining confidence inNAM journal · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Ann M RichardCenter for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency (EPA), Research Triangle Park, North Carolina 27711, United States.ORCID 0000-0003-2116-2300
Dingyin TaoDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States.ORCID 0000-0001-6531-2740
Christopher A LeClairDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States.ORCID 0000-0002-2746-5938
William LeisterDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States.
Kirill V TretyakovBiomolecular Measurement Division, National Institute of Standards and Technology (NIST), Gaithersburg, Maryland 20899, United States.
Edward WhiteBiomolecular Measurement Division, National Institute of Standards and Technology (NIST), Gaithersburg, Maryland 20899, United States.
Ken C LewisOpAns, Durham, North Carolina 27713, United States.
Andrea SeflerOpAns, Durham, North Carolina 27713, United States.
Paul ShinnDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States.
Bradley J CollinsDivision of Translational Toxicology (DTT), National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, United States.
Dac-Trung NguyenDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States.
Lin YeDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States.
Tongan ZhaoDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States.
Tuan XuDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States.
Antony J WilliamsCenter for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency (EPA), Research Triangle Park, North Carolina 27711, United States.ORCID 0000-0002-2668-4821
Suramya WaidyanathaDivision of Translational Toxicology (DTT), National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, United States.
Russell S ThomasCenter for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency (EPA), Research Triangle Park, North Carolina 27711, United States.ORCID 0000-0002-2340-0301
Raymond TiceDivision of Translational Toxicology (DTT), National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, United States.
Anton SimeonovDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States.
Ruili HuangDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States.ORCID 0000-0001-8886-8311

Funding

NIEHS NIH HHS Y02 ES007020
6 · The paper itself

Abstract

The analytical quality of compounds subjected to high-throughput screening (HTS) impacts accurate interpretation of assay results, with poor quality samples potentially leading to false negatives or positives. The Tox21 "10K" library consists of over 8900 unique compounds, spanning a diverse landscape of environmental and pharmaceutical chemicals, posing opportunities and challenges for analytical quality control (QC) determinations. Tox21 sample plates stored in DMSO at ambient conditions for 0 (T0) and/or 4 months (T4), totaling more than 13K unique sample identifiers (Tox21 IDs), were subjected to various analyses, including liquid and gas chromatography mass spectrometry (LC-MS, GC-MS) and nuclear magnetic resonance (NMR). Results for each sample at T0 or T4 underwent expert review and, where possible, a QC grade conveying purity, identity, and concentration was assigned. Herein, we relate details of the methods applied and report on the original (v0) Tox21 ID level results. Thirteen QC grades were condensed to 5 quality scores to aid global analysis, resulting in reinterpretation and improvement of >700 sample grades. Of the 92% T0 samples successfully graded, 76% exceeded 90% purity. For 76% of samples that were also tested at T4, 89% showed no evidence of sample loss or degradation. Prioritized quality bins were used to summarize thousands of replicate sample-level QC results to a compound-level QC score to support structure-based analyses. ToxPrint chemotype analysis identified structural features enriched in unstable compounds, as well as in high and low quality T0 subsets. Predicted vapor pressure was weakly correlated with low-concentration QC indicators, reflecting likely entanglement with method amenability and quality issues. Finally, an ongoing EPA effort to re-evaluate the original QC spectra is generating insights that will further modify QC grades. Tox21 QC spectra and results will be made available in a new public QC browser, facilitating further evaluation to support HTS interpretation and modeling applications.

Indexed as

High-Throughput Screening AssaysSmall Molecule LibrariesChromatography, LiquidGas Chromatography-Mass SpectrometryMagnetic Resonance SpectroscopyPharmaceutical PreparationsQuality ControlPharmaceutical PreparationsSmall Molecule Libraries

Identifiers

PMID39829241
PMCPMC11752516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.